> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Deadline Extended on Real-World Data Opportunity
- URL: https://www.fdaweb.com/deadline-extended-on-real-world-data-opportunity/
- Published: 2020-04-13T12:00:00.000Z
- Updated: 2026-09-14T16:11:05.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5146548

FDA has extended until 6/5 the deadline to apply for a[ funding opportunity](https://u7061146.ct.sendgrid.net/ls/click?upn=LHDupLGQbJrIBf0glmWFG56-2F5cjxsvy-2BRYfSGVpJePD7HtQ-2FDW20Nz0QZZNd-2FDHbRiKYcb6MbVwbAZC7juVf7XmEyOEdOTOge-2BnmEASbmnnyW0WRwGASs5vJqwu9-2FL4ut8Xkx9HqHB6KJVNRipnHBvhPoki2dKd0A4PLiLs-2BCHG3MGj-2Fp3FcJNYe7gfFZkKCOxT0aN1dWQXEjMx5ifWbMJwAMdB3V5HT6PrI7Tlws2Nj5fH23l8D3ZdkQNWMuaW1odFK6vXZzSUpIXHoyvFJQTN17UsJVfp-2BsltXnJyNfepHq3SbSKdS1QqgxihXqlhVDzgrjLszZDZRzTEkNJTOY-2BQNWkvw2pGcO0XsmY5L4iW5xIMCBud8qMFZrcklUoIq-2FOSokQ-2F7Efjc3WbAHaQWzg-3D-3DnxdT%5Ff0D7hj0BJ4b-2F7NuVqzPDs7FGiq8VLIwAX0sPSotqoLIZH-2BlHUpIN1Fpx16wXLzBItZQB-2B865N-2BRM-2FfR3UV9b-2B-2Bk4OtA9jD9Cf2kF2Wjg6TnU2fbAprEf-2FsTi-2Baymp44i-2BQNRz8UntLncWd0rwHR68o4lxWOBMyjU3JyagrLb1HESA-2FAZlnEVujBXyLXu0soRLj2pypfooe-2FQpatcBQ66L8s-2F1huMF1pJOv2V8eaGywZ0lBuj9yi06Q-2Bs7PqZFyfq2rz-2BoSnkxdQ8Ei0WAZvDlt4RrrawktBFnOMR9bKR1FJW3MZiuZeKrxyXeN-2FyR-2FfSy1aLCvEwtCoiQ1LTqzmdtZK1GfygSWH-2BvffKIBMJjFI-3D&ref=fdaweb.com) to examine the use of real-world data (RWD) to generate real-world evidence (RWE) in regulatory decision-making. FDA intends to encourage innovative approaches to further explore RWD use while making sure that scientific evidence supporting marketing approvals meets its high evidentiary standards, [according to the agency](https://www.fda.gov/medical-devices/blood-glucose-monitoring-devices/faqs-home-use-blood-glucose-meters-utilized-within-hospitals-during-covid-19-pandemic?ref=fdaweb.com). “FDA is particularly interested in projects that compare use of RWD and generation of RWE with more traditional approaches and methods for data collection and evidence generation,” it says.

The funding opportunity covers projects that focus on exploring and conducting innovative clinical trials; explaining ways to address challenges to using RWD in research studies; exploring innovative technologies; designing and conducting pilot projects; determining endpoints that RWD can capture; and evaluating reliability considerations around RWD use.